Mark Andrew Wilson, SVP & General Counsel at NEKTAR THERAPEUTICS (NKTR), sold 3,136 shares at $3.95 ($12K) on 2022-05-16, disclosed to the SEC on 2022-05-17.
Open-market sale of $12k NKTR by SVP & General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NKTR | SELL | 2025-05-21 | $7K | — | Filing → |
| NKTR | SELL | 2025-02-21 | $11K | — | Filing → |
| NKTR | SELL | 2024-12-26 | $45K | — | Filing → |